Everest Organics Ltd. · BSE:EVERESTO

Everest Organics — Investor Presentation (2020)

16 slides from Everest Organics's investor presentation, 2020

  1. Slide 1: Welcome to Everest Organics Limited

    Everest Organics Limited Welcome to Everest Organics Limited Company Profile

  2. Slide 2: Disclaimer

    Everest Organics Limited Disclaimer Everest Organics Limited may from time to time make written and oral forward-looking statements in addition to statements contained in the company’s filing with BSE Limited (BSE) and other reports to share holders. The company does not undertake to update any pers

  3. Slide 3: About Us

    Everest Organics Limited About Us  Everest Organics Limited is a Company incorporated in the year 1995 as a public listed company engaged in the business of Manufacturing and sale of Active Pharmaceutical Ingredients and Intermediates.  Dr. Sri Kakarlapudi Srihari Raju, (MD, MBBS), is a Promoter a

  4. Slide 4: Business Overview

    Everest Organics Limited Business Overview  Products and Development − The state of art USFDA facility at a single location has nearly 15% of global prazole market share. The portfolio has diversified beyond prazoles and includes Omeprazole, Esomeprazole, Pantoprazole, Fenofibrate, Dexlansoprazole,

  5. Slide 5: Business Overview

    Everest Organics Limited Business Overview  Manufacturing Capability − The plant is approved by cGMP, cGLP, WHO GMP and global regulatory authorities such as USFDA. − Certified by:  ISO 9001:2015;  EMS 14001:2015;  OHSAS 18001:2007.  Financial Snapshot − FY20 Revenues of Rs. 168 Cr. − FY20 PAT

  6. Slide 6: Financial Performance

    Everest Organics Limited Financial Performance Annual Income Growth 168,66,51,691 156,39,30,473 1,800,000,000 Particulars 2017-18 2018-19 2019-20 1,600,000,000 1,400,000,000 112,87,30,996 Total Income 112,87,30,996 156,39,30,473 168,66,51,691 1,200,000,000 1,000,000,000 PBIDT 7,78,23,388 18,37,64,98

  7. Slide 7: Credit Rating

    Everest Organics Limited Credit Rating Particulars 2016-17 2017-18 2018-19 2019-20 Agency CRISIL ICRA ICRA Brickwork Rating Fund Based-Term B-/Stable BB- BB BWR BBB-/Stable Loan Non-Fund Based A4 A4 A4+ BWR A3 Limits Fund Based Limits B-/Stable/A4 BB-/A4 BB/A4+ BWR A3

  8. Slide 8: Products Offered

    Everest Organics Limited Products Offered GLOBAL MARKET LEADERS IN PRAZOLE SEGMENT OMEPRAZOLE ESOMEPRAZOLE PANTOPRAZOLE FENOFIBRATE DEXLANSOPRAZOLE RABEPRAZOLE ITRACONAZOLE RIVAROXABAN FEBUXOSTAT OSELTAMIVIR (TAMIFLU) (Covid related) REMDESIVIR IS UNDER R&D TRIAL

  9. Slide 9: Value Added Chain (Green Initiative)

    Everest Organics Limited Value Added Chain (Green Initiative) Ammonium Sulphate, Calcium Sulphate, Calcium Nitrate, Disodium Waste to Value Added Phosphate, Potasium Nitrate, Tri Sodium Phosphate, Sodium Di Acetate, Product Sodium Acetate, Sodium Sulphate, Sodium Nitrate, Potasium Chloride.  Derive

  10. Slide 10: Key Products

    Everest Organics Limited Key Products Name of the Product Grade Therapeutic Category Omeprazole IP/BP/USP/ Ph.Eur Anti ulcerant Esomeprazole Magnesium IP/BP/USP/Ph.Eur Anti ulcerant Trihydrate Pantoprazole Sodium Sesquihydrate IP/BP/ Ph.Eur Anti ulcerant Pantoprazole Sodium USP Anti ulcerant Omepraz

  11. Slide 11: List of Intermediates

    Everest Organics Limited List of Intermediates Name of the Product Related API’s 2-Chloro methyl-3,5-Dimethyl-4-Methoxy Pyridine Hydrochloride (Chloro Omeprazole compound) 2-Mercapto-5-Methoxy Benzimidazole Omeprazole 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl) methyl]thio]-1H- Omeprazole Ben

  12. Slide 12: Future Growth Plan

    Everest Organics Limited Future Growth Plan Strategy in Place for Next COVID - 19 Development Plan Growth Phase Plans to enter into Enhanced Focus on Antiviral Phytochemical-immune segment Segments, Covid-19 and Future Develop and Manufacture vitamin with Curcumin and Piperine virus related products

  13. Slide 13: Organization Chart

    Everest Organics Limited Organization Chart

  14. Slide 14: Contact Person

    Everest Organics Limited Contact Person Ms. Rekha Singh Company Secretary Contact No. +91-40-40028838 E-mail: eolcs0405@gmail.com IR/ Legal Consultant: VB ADVISORY E-mail: vbadvisory123@gmail.com

  15. Slide 15: Factory Site

    Everest Organics Limited Factory Site

  16. Slide 16: Thank You

    Everest Organics Limited Thank You

Everest Organics — Investor Presentation (2020) on 6ix